The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome
Journal of Clinical and Experimental Dermatology Research
doi 10.4172/2155-9554.1000345
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
OMICS Publishing Group